ADC Modeling and Design with Certara IQ™ Video ADC Modeling and Design with Certara IQ™ Discover how Certara IQ helps optimize antibody-drug conjugate properties through mechanistic modeling and early feasibility…CertaraOctober 16, 2025
Prebuilt Pharmacology Models in Certara IQ™ Video Prebuilt Pharmacology Models in Certara IQ™ Certara IQ Pharmacology Models | Prebuilt Mechanistic Models for Faster QSP ResearchCertaraOctober 16, 2025
QSP Modeling for Inflammatory Bowel Disease (IBD) with Certara IQ™ Video QSP Modeling for Inflammatory Bowel Disease (IBD) with Certara IQ™ Learn how Certara IQ’s IBD model enables simulation of complex immune pathways to optimize therapeutic…CertaraOctober 16, 2025
Modeling Alzheimer’s Disease with Certara IQ™ Video Modeling Alzheimer’s Disease with Certara IQ™ Explore Certara IQ’s Alzheimer’s Disease model, enabling researchers to simulate neurodegenerative pathways, test therapies, and…CertaraOctober 16, 2025
Early Feasibility Assessment (EFA) with Certara IQ™ Video Early Feasibility Assessment (EFA) with Certara IQ™ Learn how Certara IQ performs early feasibility assessments (EFA) to predict biotherapeutic dosing, guide candidate…CertaraOctober 16, 2025
Certara IQ™: Predicting Recommended Phase 2 Doses with Confidence Video Certara IQ™: Predicting Recommended Phase 2 Doses with Confidence Learn how Certara IQ predicts recommended Phase 2 doses using advanced QSP modeling workflows that…CertaraOctober 16, 2025
Certara IQ™: Model-Informed First-In-Human (FIH) Dose Selection Video Certara IQ™: Model-Informed First-In-Human (FIH) Dose Selection Discover how Certara IQ uses QSP modeling to predict safe and effective First-In-Human doses, accelerating…CertaraOctober 16, 2025
Inside Certara IQ™: Building the Future of QSP with Josh Apgar & Chris Bouton Video Inside Certara IQ™: Building the Future of QSP with Josh Apgar & Chris Bouton Hear from Certara experts on how Certara IQ modernizes QSP modeling with AI, collaboration tools,…CertaraOctober 16, 2025
From Cost Center to Value Driver: Making the Case for Total Value of Ownership (TVO) in Life Sciences Blog From Cost Center to Value Driver: Making the Case for Total Value of Ownership (TVO) in Life Sciences Shift from Total Cost of Ownership to Total Value of Ownership in life sciences, showcasing…CertaraOctober 16, 2025
Streamlining PK/PD Reporting: A Smarter Approach to Generating Tables, Figures and Listings Blog Streamlining PK/PD Reporting: A Smarter Approach to Generating Tables, Figures and Listings Discover how TFL Studio accelerates PK/PD reporting. Create audit-ready tables, figures, and listings faster with…CertaraOctober 16, 2025